BP clinical trials

A Multi-center, Randomized Parallel Group, Placebo-Controlled Double-Blind Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therapy in Pediatric Patients with Systemic Lupus Erythematosus (SLE)

This study is looking at a new medicine called belimumab (Benlysta) for children and teenagers with lupus. We want to see if it's safe, helps manage the condition, and how the body uses it, when given alongside their usual lupus treatments.